Solomon DH - Search Results

1

Validation of claims-based algorithms for gout flares.

MacFarlane LA, Liu CC, Solomon DH, Kim SC. MacFarlane LA, et al. Among authors: solomon dh. Pharmacoepidemiol Drug Saf. 2016 Jul;25(7):820-6. doi: 10.1002/pds.4044. Epub 2016 May 27. Pharmacoepidemiol Drug Saf. 2016. PMID: 27230083 Free PMC article.

2

Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records.

Kiyota Y, Schneeweiss S, Glynn RJ, Cannuscio CC, Avorn J, Solomon DH. Kiyota Y, et al. Among authors: solomon dh. Am Heart J. 2004 Jul;148(1):99-104. doi: 10.1016/j.ahj.2004.02.013. Am Heart J. 2004. PMID: 15215798

3

Statin lipid-lowering drugs and bone mineral density.

Solomon DH, Finkelstein JS, Wang PS, Avorn J. Solomon DH, et al. Pharmacoepidemiol Drug Saf. 2005 Apr;14(4):219-26. doi: 10.1002/pds.984. Pharmacoepidemiol Drug Saf. 2005. PMID: 15386702

4

Educational outreach (academic detailing) regarding osteoporosis in primary care.

Polinski JM, Brookhart MA, Katz JN, Arnold M, Kristeller J, Trombetta D, Tadduni ME, Golomb MJ, Solomon DH. Polinski JM, et al. Among authors: solomon dh. Pharmacoepidemiol Drug Saf. 2005 Dec;14(12):843-50. doi: 10.1002/pds.1120. Pharmacoepidemiol Drug Saf. 2005. PMID: 15918162 Clinical Trial.

5

Identification of individuals with CKD from Medicare claims data: a validation study.

Winkelmayer WC, Schneeweiss S, Mogun H, Patrick AR, Avorn J, Solomon DH. Winkelmayer WC, et al. Among authors: solomon dh. Am J Kidney Dis. 2005 Aug;46(2):225-32. doi: 10.1053/j.ajkd.2005.04.029. Am J Kidney Dis. 2005. PMID: 16112040

6

Confounder summary scores when comparing the effects of multiple drug exposures.

Cadarette SM, Gagne JJ, Solomon DH, Katz JN, Stürmer T. Cadarette SM, et al. Among authors: solomon dh. Pharmacoepidemiol Drug Saf. 2010 Jan;19(1):2-9. doi: 10.1002/pds.1845. Pharmacoepidemiol Drug Saf. 2010. PMID: 19757416 Free PMC article.

7

NSAID switching and short-term gastrointestinal outcome rates after the withdrawal of rofecoxib.

Schneeweiss S, Glynn RJ, Avorn J, Mamdani M, Mogun H, Solomon DH. Schneeweiss S, et al. Among authors: solomon dh. Pharmacoepidemiol Drug Saf. 2009 Dec;18(12):1134-42. doi: 10.1002/pds.1826. Pharmacoepidemiol Drug Saf. 2009. PMID: 19844943

8

Validation of rheumatoid arthritis diagnoses in health care utilization data.

Kim SY, Servi A, Polinski JM, Mogun H, Weinblatt ME, Katz JN, Solomon DH. Kim SY, et al. Among authors: solomon dh. Arthritis Res Ther. 2011 Feb 23;13(1):R32. doi: 10.1186/ar3260. Arthritis Res Ther. 2011. PMID: 21345216 Free PMC article.

9

Accuracy of identifying neutropenia diagnoses in outpatient claims data.

Kim SY, Solomon DH, Liu J, Chang CL, Daniel GW, Schneeweiss S. Kim SY, et al. Among authors: solomon dh. Pharmacoepidemiol Drug Saf. 2011 Jul;20(7):709-13. doi: 10.1002/pds.2157. Epub 2011 May 12. Pharmacoepidemiol Drug Saf. 2011. PMID: 21567653 Free PMC article.

10

Simultaneously assessing intended and unintended treatment effects of multiple treatment options: a pragmatic "matrix design".

Rassen JA, Solomon DH, Glynn RJ, Schneeweiss S. Rassen JA, et al. Among authors: solomon dh. Pharmacoepidemiol Drug Saf. 2011 Jul;20(7):675-83. doi: 10.1002/pds.2121. Epub 2011 May 30. Pharmacoepidemiol Drug Saf. 2011. PMID: 21626604

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

911 results

Search Page